Millipore Sigma Vibrant Logo

474790 MG-132 - CAS 133407-82-6 - Calbiochem

A cell-permeable, potent, reversible proteasome inhibitor (Ki = 4 nM).

MG-132 - CAS 133407-82-6 - Calbiochem: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal, Z-LLL-CHO, Proteasome Inhibitor XI

Primary Target: proteasome
View Products on Sigmaaldrich.com
474790
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
133407-82-6C₂₆H₄₁N₃O₅

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
474790-10MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 10 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      474790-1MG
      Comprobando disponibilidad...
      —
      Disponibilidad a confirmar Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          		 Ampolla de plást. 1 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          —
          Solicitar precio
          		 —
          474790-20MG
          Comprobando disponibilidad...
          —
          Disponibilidad a confirmar Disponibilidad a confirmar
          Ingrese cantidad 
          Suspendido
          Cantidades limitadas disponibles
          Debe confirmarse disponibilidad
            El resto: se avisará
              El resto: se avisará
              Se avisará
              Póngase en contacto con el Servicio de Atención al Cliente
              Contact Customer Service

              		 20 mg
              Recuperando precio...
              No pudo obtenerse el precio
              La cantidad mínima tiene que ser múltiplo de
              Maximum Quantity is
              Al finalizar el pedido Más información
              Ahorró ()
               
              —
              Solicitar precio
              		 —
              474790-5MG
              Comprobando disponibilidad...
              —
              Disponibilidad a confirmar Disponibilidad a confirmar
              Ingrese cantidad 
              Suspendido
              Cantidades limitadas disponibles
              Debe confirmarse disponibilidad
                El resto: se avisará
                  El resto: se avisará
                  Se avisará
                  Póngase en contacto con el Servicio de Atención al Cliente
                  Contact Customer Service

                  		 Ampolla de plást. 5 mg
                  Recuperando precio...
                  No pudo obtenerse el precio
                  La cantidad mínima tiene que ser múltiplo de
                  Maximum Quantity is
                  Al finalizar el pedido Más información
                  Ahorró ()
                   
                  —
                  Solicitar precio
                  		 —
                  Description
                  OverviewA potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM). Reduces the degradation of ubiquitin-conjugated proteins in mammalian cells and permeable strains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. Activates c-Jun N-terminal kinase (JNK1), which initiates apoptosis. Inhibits NF-κB activation (IC50 = 3 µM). Also reported to increases the survival rate of mesenchymal stem cells following their transplantation. Prevents β-secretase cleavage. A 10 mM (1 mg/210 µl) solution of MG-132 (Cat. No. 474791) in DMSO is also available. This material is ≥98% pure by HPLC. A material with ≥95% purity by HPLC (Cat. No. 474787) is also available.
                  Catalogue Number474790
                  Brand Family Calbiochem®
                  SynonymsCarbobenzoxy-L-leucyl-L-leucyl-L-leucinal, Z-LLL-CHO, Proteasome Inhibitor XI
                  References
                  ReferencesLi, Z.W. et al. 2011. Sheng Li Xue Bao. 63, 525.
                  Steinhilb, M.L., et al. 2001. J. Biol. Chem. 276, 4476.
                  Meriin, A.B., et al. 1998. J. Biol. Chem. 273, 6373.
                  Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem. 31, 279.
                  Klafki, H.W., et al. 1996. J. Biol. Chem. 271, 2865.
                  Lee, D.H., and Goldberg, A.L., 1996. J. Biol. Chem. 271, 27280.
                  Wiertz, E.J., et al. 1996. Cell 84, 769.
                  Jensen, T.J., et al. 1995. Cell 83, 129.
                  Read, M.A., et al. 1995. Immunity 2, 493.
                  Rock, K.L., et al. 1994. Cell 78, 761.
                  Product Information
                  CAS number133407-82-6
                  ATP CompetitiveN
                  FormWhite solid
                  Hill FormulaC₂₆H₄₁N₃O₅
                  Chemical formulaC₂₆H₄₁N₃O₅
                  ReversibleY
                  Structure formula ImageStructure formula Image
                  Quality LevelMQ100
                  Applications
                  Biological Information
                  Primary Targetproteasome
                  Primary Target IC<sub>50</sub>3 µM against NF-κB activation
                  Primary Target K<sub>i</sub>4 nM against proteasome
                  Purity≥98% by HPLC
                  Physicochemical Information
                  Cell permeableY
                  Peptide SequenceZ-Leu-Leu-Leu-CHO
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  Safety Information
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Ambient Temperature Only
                  Toxicity Standard Handling
                  Storage -20°C
                  Do not freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
                  Packaging Information
                  Transport Information
                  Supplemental Information
                  Specifications
                  Global Trade Item Number
                  Número de referencia GTIN
                  474790-10MG 04055977185485
                  474790-1MG 07790788050436
                  474790-20MG 04055977185492
                  474790-5MG 07790788050443

                  Documentation

                  MG-132 - CAS 133407-82-6 - Calbiochem Ficha datos de seguridad (MSDS)

                  Título

                  Ficha técnica de seguridad del material (MSDS) 

                  MG-132 - CAS 133407-82-6 - Calbiochem Certificados de análisis

                  CargoNúmero de lote
                  474790

                  Referencias bibliográficas

                  Visión general referencias
                  Li, Z.W. et al. 2011. Sheng Li Xue Bao. 63, 525.
                  Steinhilb, M.L., et al. 2001. J. Biol. Chem. 276, 4476.
                  Meriin, A.B., et al. 1998. J. Biol. Chem. 273, 6373.
                  Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem. 31, 279.
                  Klafki, H.W., et al. 1996. J. Biol. Chem. 271, 2865.
                  Lee, D.H., and Goldberg, A.L., 1996. J. Biol. Chem. 271, 27280.
                  Wiertz, E.J., et al. 1996. Cell 84, 769.
                  Jensen, T.J., et al. 1995. Cell 83, 129.
                  Read, M.A., et al. 1995. Immunity 2, 493.
                  Rock, K.L., et al. 1994. Cell 78, 761.

                  Folleto

                  Cargo
                  Caspases and other Apoptosis Related Tools Brochure
                  Proteasomes Technical Bulletin

                  Citas

                  Título
                • Li, Z.W. et al. 2011. Sheng Li Xue Bao. 63, 525.
                • Kamynina, E., et al. 2007. Molecular and Cellular Biology 27, 1809.
                • Yolanda Fernandez, et al. (2006) Chemical Blockage of the Proteasome Inhibitory Function of Bortezomib: Impact on Tumor Cell Death. Journal of Biological Chemistry 281, 1107-1118.
                • Markus D. Lacher, et al. (2006) Transforming Growth Factor-{beta} Receptor Inhibition Enhances Adenoviral Infectability of Carcinoma Cells via Up-Regulation of Coxsackie and Adenovirus Receptor in Conjunction with Reversal of Epithelial-Mesenchymal Transition. Cancer Research 66, 1648-1657.
                • Chen, L., et al. 2005. Molecular Cancer Therapeutics 4, 1311.
                • Emily I. Chen, et al. (2005) Maspin alters the carcinoma proteome. FASEB Journal in press,.
                • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
                • Zaibo Li, et al. (2005) VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α. European Molecular Biology Organization Reports 6, 373-378.
                • Yasuyuki Miyake, et al. (2005) Novel splicing variant of mouse orc1 is deficient in nuclear translocation and resistant for proteasome-mediated degradation. Journal of Biological Chemistry 280, 12643-12652.
                • Dana Ungermannova, Yuefeng Gao and Xuedong Liu. (2005) Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2. Journal of Biological Chemistry 280, 30301-30309.
                • Chuan-Jin Wu, et al. (2005) TNF-α induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. European Molecular Biology Organization Journal 24, 1886-1898.
                • Zhigang Zhang, Jin-Ying Wu, William Hait and Jin-Ming Yang. (2004) Regulation of the stability of P-glycoprotein by ubiquitination.. Molecular Pharmacology 66, 395-403.
                • Gloria Bonuccelli, et al. (2003) Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. American Journal of Pathology 163, 1663-1675.
                  		•
                  Ficha técnica

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision27-February-2012 RFH
                  SynonymsCarbobenzoxy-L-leucyl-L-leucyl-L-leucinal, Z-LLL-CHO, Proteasome Inhibitor XI
                  DescriptionPotent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM). Reduces the degradation of ubiquitin-conjugated proteins in mammalian cells and permeable stains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. Activates c-Jun N-terminal kinase (JNK1) which initiates apoptosis. Inhibits NF-kB activation (IC50 = 3 µM). Also reported to increases the survival rate of mesenchymal stem cells following their transplantation.
                  FormWhite solid
                  CAS number133407-82-6
                  Chemical formulaC₂₆H₄₁N₃O₅
                  Peptide SequenceZ-Leu-Leu-Leu-CHO
                  Structure formulaStructure formula
                  Purity≥98% by HPLC
                  SolubilityDMSO (20 mg/ml) or Ethanol (20 mg/ml)
                  Storage -20°C
                  Do Not Freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
                  Toxicity Standard Handling
                  ReferencesLi, Z.W. et al. 2011. Sheng Li Xue Bao. 63, 525.
                  Steinhilb, M.L., et al. 2001. J. Biol. Chem. 276, 4476.
                  Meriin, A.B., et al. 1998. J. Biol. Chem. 273, 6373.
                  Adams, J., and Stein, R. 1996. Ann. Rep. Med. Chem. 31, 279.
                  Klafki, H.W., et al. 1996. J. Biol. Chem. 271, 2865.
                  Lee, D.H., and Goldberg, A.L., 1996. J. Biol. Chem. 271, 27280.
                  Wiertz, E.J., et al. 1996. Cell 84, 769.
                  Jensen, T.J., et al. 1995. Cell 83, 129.
                  Read, M.A., et al. 1995. Immunity 2, 493.
                  Rock, K.L., et al. 1994. Cell 78, 761.
                  Citation
                • Li, Z.W. et al. 2011. Sheng Li Xue Bao. 63, 525.
                • Kamynina, E., et al. 2007. Molecular and Cellular Biology 27, 1809.
                • Yolanda Fernandez, et al. (2006) Chemical Blockage of the Proteasome Inhibitory Function of Bortezomib: Impact on Tumor Cell Death. Journal of Biological Chemistry 281, 1107-1118.
                • Markus D. Lacher, et al. (2006) Transforming Growth Factor-{beta} Receptor Inhibition Enhances Adenoviral Infectability of Carcinoma Cells via Up-Regulation of Coxsackie and Adenovirus Receptor in Conjunction with Reversal of Epithelial-Mesenchymal Transition. Cancer Research 66, 1648-1657.
                • Chen, L., et al. 2005. Molecular Cancer Therapeutics 4, 1311.
                • Emily I. Chen, et al. (2005) Maspin alters the carcinoma proteome. FASEB Journal in press,.
                • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
                • Zaibo Li, et al. (2005) VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α. European Molecular Biology Organization Reports 6, 373-378.
                • Yasuyuki Miyake, et al. (2005) Novel splicing variant of mouse orc1 is deficient in nuclear translocation and resistant for proteasome-mediated degradation. Journal of Biological Chemistry 280, 12643-12652.
                • Dana Ungermannova, Yuefeng Gao and Xuedong Liu. (2005) Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2. Journal of Biological Chemistry 280, 30301-30309.
                • Chuan-Jin Wu, et al. (2005) TNF-α induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination. European Molecular Biology Organization Journal 24, 1886-1898.
                • Zhigang Zhang, Jin-Ying Wu, William Hait and Jin-Ming Yang. (2004) Regulation of the stability of P-glycoprotein by ubiquitination.. Molecular Pharmacology 66, 395-403.
                • Gloria Bonuccelli, et al. (2003) Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. American Journal of Pathology 163, 1663-1675.
                  		•